AIM Biotech
PrivateLast Round
Grant
Aug 20, 2021
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AIM Biotech is a biotechnology company that develops and provides organ-on-a-chip systems, also known as 3D cell culture platforms, for use in medical research, drug discovery, and clinical investigation.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AIM Biotech Comparables
Compare AIM Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beonchip | 89% | |
| AlveoliX AG | 88% | |
| Akita | 86% | |
AIM Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 20, 2021 | ||||
| Series A | Nov 19, 2020 | ||||
| Seed | Sep 4, 2016 |
AIM Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Series A |
| Black Kite Capital | Series A |
| Wavemaker Three-Sixty Health | Series A |
| Wavemaker Ventures | Series A |
| Venturecraft | Series A, Seed |
| SMART Innovation Centre | Grant |
| Elev8.vc | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 82% MoM.
- Jan 1, 2026
Monthly visitors grew 40% MoM, from 3K to 4.2K.
AIM Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AIM Biotech's valuation, stock price, and market status.